Invesco Ltd. lifted its holdings in B2Gold Corp. (NYSE:BTG – Free Report) by 32.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,987,385 shares of the company’s stock after buying an additional 3,939,040 shares during the period. Invesco Ltd. owned approximately 1.21% of B2Gold worth $39,009,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also bought and sold shares of BTG. Norges Bank purchased a new stake in shares of B2Gold during the 4th quarter valued at approximately $40,192,000. American Century Companies Inc. lifted its stake in B2Gold by 31.3% during the 4th quarter. American Century Companies Inc. now owns 22,658,771 shares of the company’s stock worth $55,436,000 after acquiring an additional 5,401,334 shares in the last quarter. Amundi lifted its position in shares of B2Gold by 37.4% during the fourth quarter. Amundi now owns 8,139,040 shares of the company’s stock worth $21,243,000 after purchasing an additional 2,215,319 shares in the last quarter. Vanguard Group Inc. boosted its position in B2Gold by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 53,010,477 shares of the company’s stock valued at $129,823,000 after buying an additional 1,165,204 shares during the period. Finally, JPMorgan Chase & Co. increased its position in shares of B2Gold by 210.7% during the fourth quarter. JPMorgan Chase & Co. now owns 1,608,343 shares of the company’s stock worth $3,924,000 after acquiring an additional 1,090,768 shares during the period. 61.40% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have commented on BTG. Scotiabank raised shares of B2Gold from a “hold” rating to a “strong-buy” rating in a research report on Monday. TD Securities cut B2Gold from a “buy” rating to a “hold” rating in a research report on Tuesday, February 4th. Raymond James reissued an “outperform” rating and set a $4.50 price objective on shares of B2Gold in a research report on Friday, April 4th. Bank of America downgraded B2Gold from a “buy” rating to an “underperform” rating in a research note on Tuesday, January 14th. Finally, National Bankshares reiterated an “outperform” rating on shares of B2Gold in a research note on Wednesday, April 2nd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, B2Gold has a consensus rating of “Hold” and an average price target of $4.21.
B2Gold Trading Up 1.2 %
Shares of BTG stock opened at $3.35 on Thursday. B2Gold Corp. has a fifty-two week low of $2.20 and a fifty-two week high of $3.51. The company has a quick ratio of 1.08, a current ratio of 1.83 and a debt-to-equity ratio of 0.07. The business has a fifty day simple moving average of $2.87 and a 200-day simple moving average of $2.82. The stock has a market cap of $4.42 billion, a P/E ratio of -6.98, a P/E/G ratio of 0.33 and a beta of 0.93.
B2Gold Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Friday, March 7th were paid a $0.02 dividend. This represents a $0.08 dividend on an annualized basis and a yield of 2.39%. The ex-dividend date was Friday, March 7th. B2Gold’s payout ratio is currently -16.67%.
B2Gold Profile
B2Gold Corp. operates as a gold producer company. It operates the Fekola Mine in Mali, the Masbate Mine in the Philippines, and the Otjikoto Mine in Namibia. The company also has an 100% interest in the Gramalote gold project in Colombia; 24% interest in the Calibre Mining Corp.; and approximately 19% interest in BeMetals Corp.
Recommended Stories
- Five stocks we like better than B2Gold
- How to Buy Gold Stock and Invest in Gold
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- How to Invest in Biotech Stocks
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for B2Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for B2Gold and related companies with MarketBeat.com's FREE daily email newsletter.